Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin Y. ChaoJ. S. ChenA. W. Alberts OriginalPaper Pages: S11 - S14
Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase H. Y. Pan OriginalPaper Pages: S15 - S18
Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor T. A. Miettinen OriginalPaper Pages: S19 - S21
Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia M. J. TikkanenJ. -P. OjalaE. Helve OriginalPaper Pages: S23 - S25
Comparison of different HMG-CoA reductase inhibitors H. H. DitschuneitK. KuhnH. Ditschuneit OriginalPaper Pages: S27 - S32
Effects of bezafibrate on hepatic cholesterol metabolism D. StåhlbergE. ReihnérB. Angelin OriginalPaper Pages: S33 - S36
Bezafibrate fails to directly modulate HMG-CoA reductase or LDL catabolism in human mononuclear cells E. F. StangeM. FrühholzH. Ditschuneit OriginalPaper Pages: S37 - S40
Increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia G. FranceschiniF. BerniniC. R. Sirtori OriginalPaper Pages: S45 - S48
Coronary drug project: experience with niacin K. G. BergeP. L. CannerThe Coronary Drug Project Research Group OriginalPaper Pages: S49 - S51
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism K. EinarssonS. EricssonB. Angelin OriginalPaper Pages: S53 - S58
Mechanisms of action of plant sterols on inhibition of cholesterol absorption T. HeinemannG. -A. Kullak-UblickK. von Bergmann OriginalPaper Pages: S59 - S63
Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole Y. A. KesäniemiT. A. Miettinen OriginalPaper Pages: S65 - S67
The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implications J. L. ProbstfieldB. M. Rifkind OriginalPaper Pages: S69 - S75
Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect? B. FinckhA. NiendorfU. Beisiegel OriginalPaper Pages: S77 - S80
Clinical and therapeutic use of probucol A. BergM. W. BaumstarkJ. Keul OriginalPaper Pages: S81 - S84
Beclobrate: pharmacodynamic properties and therapeutic use in hyperlipidemia C. WannerH. WielandW. H. Hörl OriginalPaper Pages: S85 - S89
Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers H. HasibederH. J. StaabW. März OriginalPaper Pages: S91 - S94